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Genetic dissection of the glutamatergic 
neuron system in cerebral cortex
Katherine S. Matho1, Dhananjay Huilgol1,2,11, William Galbavy1,3,11, Miao He1,8,11, Gukhan Kim1,11, 
Xu An1,2, Jiangteng Lu1,9, Priscilla Wu1, Daniela J. Di Bella4, Ashwin S. Shetty4, 
Ramesh Palaniswamy1, Joshua Hatfield1,2, Ricardo Raudales1,3, Arun Narasimhan1, 
Eric Gamache1, Jesse M. Levine1,5, Jason Tucciarone1,5,10, Eric Szelenyi1, Julie A. Harris5,6, 
Partha P. Mitra1, Pavel Osten1, Paola Arlotta4,7 & Z. Josh Huang1,2 ✉
Diverse types of glutamatergic pyramidal neurons mediate the myriad processing 
streams and output channels of the cerebral cortex1,2, yet all derive from neural 
progenitors of the embryonic dorsal telencephalon3,4. Here we establish genetic 
strategies and tools for dissecting and fate-mapping subpopulations of pyramidal 
neurons on the basis of their developmental and molecular programs. We leverage 
key transcription factors and effector genes to systematically target temporal 
patterning programs in progenitors and differentiation programs in postmitotic 
neurons. We generated over a dozen temporally inducible mouse Cre and Flp knock-in 
driver lines to enable the combinatorial targeting of major progenitor types and 
projection classes. Combinatorial strategies confer viral access to subsets of 
pyramidal neurons defined by developmental origin, marker expression, anatomical 
location and projection targets. These strategies establish an experimental 
framework for understanding the hierarchical organization and developmental 
trajectory of subpopulations of pyramidal neurons that assemble cortical processing 
networks and output channels.
Pyramidal neurons (PyNs) constitute the large majority of nerve cells 
in the cerebral cortex and mediate all of the inter-areal processing 
streams and output channels1,2,4. Traditionally, PyNs have been clas-
sified into several major classes according to their laminar location 
and broad axon projection targets, such as intratelencephalic (IT) and 
extratelencephalic (ET or corticofugal), which further comprises sub-
cerebral (including pyramidal tract; PT) and corticothalamic (CT) PyNs1. 
Within these classes, subsets of PyNs form specific local and long-range 
connectivity, linking discrete microcircuits to cortical subnetworks 
and output channels1,5. Single-cell transcriptome analysis suggests 
that there are over fifty PyN transcriptomic types6. However, genetic 
tools and strategies for experimentally accessing PyN subpopulations 
are limited.
All PyNs are generated from neural progenitors in the embryonic 
dorsal telencephalon, where regionally differentiated radial glial 
progenitors (RGs) undergo asymmetric divisions, giving rise to radial 
clones of PyNs that migrate to the cortex in an inside-out order7. RGs 
generate PyNs either directly or indirectly through intermediate pro-
genitors (IPs), which divide symmetrically to generate pairs of PyNs8. 
A set of temporal patterning genes drive lineage progression in RGs, 
which unfold a conserved differentiation program in successively gen-
erated postmitotic neurons3,4,9. Resolving the lineage organization 
of diverse progenitors and their relationship to projection-defined 
PyN subpopulations requires fate-mapping tools with cell type and 
temporal resolution2.
Here we present strategies and a genetic toolkit in the mouse for 
targeting PyN subpopulations and progenitors guided by knowledge 
of their developmental programs. We leverage gene expression pat-
terns of the cell-type specification and differentiation programs to 
target biologically significant progenitor subsets, PyN subpopula-
tions and their developmental trajectories (Fig. 1a–c, Extended Data 
Table 1). These tools and strategies provide a roadmap for accessing 
hierarchically organized PyN types at progressively finer resolution. 
They will facilitate the tracking of developmental trajectories of PyNs 
for elucidating the organization and assembly of neural circuits of the 




The transcription factors LHX2 and FEZF2 act at multiple stages 
throughout corticogenesis10–12. The fate potential of and relation-
ship between Lhx2+ RGs (RGsLhx2) and Fezf2+ RGs (RGsFezf2) are largely 
unknown. We generated Lhx2-CreER, Fezf2-CreER and Fezf2-Flp driver 
lines and performed a series of fate-mapping experiments at multiple 
https://doi.org/10.1038/s41586-021-03955-9
Received: 23 April 2020
Accepted: 25 August 2021
Published online: 6 October 2021
Open access
 Check for updates
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY, USA. 2Department of Neurobiology, Duke University Medical Center, Durham, NC, USA. 3Program in Neuroscience, 
Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY, USA. 4Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. 
5Program in Neuroscience and Medical Scientist Training Program, Stony Brook University, New York, NY, USA. 6Allen Institute for Brain Science, Seattle, WA, USA. 7Stanley Center for 
Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. 8Present address: Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers 
Center for Brain Science, Fudan University, Shanghai, China. 9Present address: Shanghai Jiaotong University Medical School, Shanghai, China. 10Present address: Department of Psychiatry, 
Stanford University School of Medicine, Palo Alto, CA, USA. 11These authors contributed equally: Dhananjay Huilgol, William Galbavy, Miao He, Gukhan Kim. ✉e-mail: josh.huang@duke.edu
Nature | Vol 598 | 7 October 2021 | 183
embryonic stages to reveal these progenitors and their lineage pro-
gression, as well as their PyN progeny in the mature cortex (Fig. 1d–h, 
Extended Data Figs. 1, 2).
At embryonic day (E) 10.5, a 24-hour tamoxifen pulse-chase in 
Lhx2-CreER;Ai14 embryos resulted in dense labelling of neuroepithe-
lial cells and RGs in the dorsal pallium, with a sharp border at the cor-
tex–hem boundary (Extended Data Fig. 1a). E12.5–E13.5 pulse-chase 
revealed a prominent medialhigh to laterallow gradient of RGsLhx2 (Fig. 1d), 
suggesting differentiation of the earlier RGs. E13.5–E14.5 pulse-chase 
showed a similar gradient pattern at a lower cell density (Extended 
Data Fig. 1e). Fate-mapping from E10.5–P30, E12.5–P30 and E14.5–P30 
labelled PyN progeny across cortical layers (Fig. 1e, Extended Data 
Fig. 1b–f, p), suggesting multipotency of RGsLhx2 at these stages. During 
postnatal development, the expression of Lhx2 became postmitotic: 
pulse-chase in P5 labelled largely IT PyNs across layers and in the sec-
ond postnatal week labelled more astrocytes (around 60%) than PyNs 
across layers (Extended Data Fig. 1q–r).
Similar fate-mapping experiments using the Fezf2-CreER driver 
yielded contrasting results. At E10.5, short pulse-chase labelled only a 
sparse set of pallial RGs, ending at the cortex–hem boundary (Extended 
Data Fig. 1g). E12.5–E13.5 pulse-chase labelled a larger set of RGsFezf2  
with a similar medialhigh to laterallow gradient as RGsLhx2, with a notably 
lower density (Fig. 1f). E13.5–E14.5 pulse-chase labelled few RGs, pri-
marily in the medial region, and otherwise postmitotic PyNs (Extended 
Data Fig. 1k). Fate-mapping from E10.5–P30 and E12.5–P30 labelled 
PyNs across cortical layers, suggesting multipotent RGsFezf2 (Fig. 1g, 
Extended Data Fig. 1h, j). After E13.5, the expression of Fezf2 largely 
shifted to postmitotic layer (L) 5 and 6 (L5/6) corticofugal PyNs 
(Extended Data Fig. 1l). Both the Lhx2-CreER and the Fezf2-CreER driv-
ers recapitulate endogenous expression across developmental stages 
(Extended Data Fig. 2), thus providing fate-mapping tools for these 
progenitor pools.
To probe the relationship between RGsLhx2 and RGsFezf2, we designed 
an intersection–subtraction (IS) strategy. Combining Lhx2-CreER and 
Fezf2-Flp with an IS reporter13, we differentially labelled RGsLhx2+/Fezf2− and 
RGsLhx2+/Fezf2+ (Fig. 1i–n, Extended Data Fig. 1s, t). E11.5–E12.5 and E12.5–
E13.5 pulse-chase revealed two distinct RG subpopulations intermixed 
across the dorsal pallium, with RGsLhx2+/Fezf2− more than twice as abundant 
as RGsLhx2+/Fezf2+. Both subpopulations distributed in a medialhigh to later-
allow and rostralhigh to caudallow gradient, consistent with the patterns of 
Lhx2 and Fezf2 expression (Fig. 1j, k). Although most RGsFezf2 expressed 
LHX2, approximately 10% did not (Extended Data Fig. 2e, i), suggest-
ing that there are three distinct RG subpopulations distinguished by 
differential expression of Lhx2 and Fezf2. Notably, long pulse-chase 
revealed that whereas RGsLhx2+/Fezf2−-derived PyNs extended callosal but 
no subcortical axons—the IT type—RGsLhx2+/Fezf2+-derived PyNs extended 
subcortical but no callosal axons—the ET type (Fig. 1l–n). This result 
suggested fate-restricted RG lineages that produce categorically dis-
tinct PyN projection classes.
Neurogenic RGs
Early cortical progenitors comprise proliferative and neuro-
genic subpopulations. Tis21 (also known as Btg2) is a transcription 
co-regulator that is expressed in both pallium-derived glutamater-
gic and subpallium-derived GABAergic neurogenic RGs (nRGs)14. 
E10.5 fate-mapping in the Tis21-CreER driver line labelled columnar 
clones of PyNs and astrocytes intermixed with subpallium-derived 
GABAergic interneurons (Extended Data Fig.  3b, f, g). We used 
Tis21-CreER;Fezf2-Flp;IS mice to restrict fate-mapping to glutamater-













































































































































































Fig. 1 | Strategies and drivers to target PyN types and fate-map progenitors. 
a, Major PyN projection classes mediating intratelencephalic streams (IT, red) 
and cortical output channels (PT, blue; CT, purple) in a sagittal brain section. 
Pn, pons; SC, superior colliculus; Str, striatum; Th, thalamus; Spd, spinal cord. 
b, PyN developmental trajectory. RGs undergo direct and indirect (IP-derived) 
neurogenesis, producing all laminar and projection types. The listed genes are 
expressed in progenitor and PyN subpopulations. SVZ, subventricular zone; 
VZ, ventricular zone. c, Temporal expression patterns of genes used for 
generating knock-in drivers across PyN development. Colours correspond to 
projection class; intensity gradients depict expression levels. d, E12.5 
tamoxifen pulse-chase in Lhx2 embryos labelled RGsLhx2+ with a medialhigh to 
laterallow gradient along the dorsal neuroepithelium, ending at the cortex–hem 
boundary. The magnified views in d, f, j show RGs at multiple cell-cycle stages, 
with end-feet (arrows) and dividing soma (arrowheads) at the ventricle wall 
(dashed line). e, E12.5 RGsLhx2+ produced PyNs across cortical layers. f, E12.5 
tamoxifen pulse-chase in Fezf2 embryos labelled RGsFezf2+ with a gradient 
distribution similar to that in d but at a lower density. g, RGsFezf2+ produced PyNs 
across layers. h, Top, distribution of RGsLhx2+ (red) and RGsFezf2+ (pink) across 
cortical neuroepithelium divided into medial (M), dorsal (D) and lateral (L) 
bins. Bottom, laminar distribution of fate-mapped PyNs. i, Fate-mapping 
scheme using an IS reporter with Lhx2-CreER and Fezf2-Flp: RGsLhx2+Fezf2− express 
tdTomato/RFP by ‘Cre-NOT-Flp’ subtraction; RGsLhx2+Fezf2+ express EGFP by 
‘Cre-AND-Flp’ intersection. j, E12.5 tamoxifen 24-hour pulse-chase revealed 
RGsLhx2+Fezf2− and RGsLhx2+Fezf2+ throughout the cortical primordium. k, Top, the 
labelled number of RGsLhx2+Fezf2+ is half that of RGsLhx2+Fezf2−. Bottom, the number 
of RGsLhx2+Fezf2− versus RGsLhx2+Fezf2+ at rostral (R), mid-level (M) and caudal (C) 
sections. Data in h, k are mean ± s.e.m.; see ‘Quantification and statistics 
related to progenitor fate-mapping’ in the Methods for statistical details. l–n, 
RGLhx2+Fezf2−-derived PyNs (red) project to the corpus callosum (arrowheads, m) 
without subcortical branches; RGLhx2+Fezf2+-derived PyNs project to the thalamus 
(arrowheads, n) without callosal branches. DAPI (blue). Scale bars, 20 µm  
(d, f, j insets); 100 µm (all other panels).
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demonstrated that Tis21–Fezf2 intersection specifically labelled a set 
of pallial nRGFezf2+ with enhanced green fluorescent protein (EGFP), 
whereas Tis21–Fezf2 subtraction labelled pallial and subpallial nRGFezf2− 
with red fluorescent protein (RFP). Pallial nRGs consisted of both 
Fezf2+and Fezf2− subpopulations, suggesting heterogeneity. E12.5–
P30 fate-mapping in these mice revealed three types of PyN clones 
(Extended Data Fig. 3i-k). RFP-only clones are likely to have derived from 
nRGFezf2− in which Tis21-CreER activated RFP expression; they probably 
consisted of PyNs that did not express Fezf2 at any stage. EGFP-only 
clones are likely to have derived from nRGFezf2+, in which Tis21-CreER 
and Fezf2-Flp co-expression activated EGFP in the IS reporter allele. 
Mixed clones containing both EGFP and RFP cells probably derived 
from nRGFezf2− in which Tis21-CreER activated RFP expression followed 
by postmitotic activation of EGFP through Fezf2-Flp. Together, these 
results indicate the presence of nRGFezf2+ and nRGFezf2−, both multipotent 
in generating PyNs across all cortical layers.
IPs
IPs and indirect neurogenesis have evolved largely in the mammalian 
lineage and have further expanded in primates14,15. Along the neural 
tube, IP-mediated indirect neurogenesis is restricted to the telencepha-
lon and is thought to contribute to the expansion of cell numbers and 
diversity in the neocortex. The majority of PyNs in mouse cortex are 
produced through IPs16,17, but the link between indirect neurogenesis 
and PyN types remains unclear. The T-box transcription factor Tbr2 
(also known as Eomes) is expressed in pallial IPs throughout indirect 
neurogenesis18. E16.5 pulse-chase in the Tbr2-CreER driver line specifi-
cally labelled IPs (Extended Data Fig. 3a, c). E16.5 and E17.5 fate-mapping 
labelled PyNs in L2/3 and upper L2, respectively (Fig. 2c, d, Extended 
Data Fig. 3d). Therefore, the Tbr2-CreER driver enables highly restricted 
laminar targeting of PyN subpopulations in supragranular layers. 
Furthermore, Tis21-CreER and Tbr2-FlpER intersection enabled specific 
targeting of neurogenic but not the transit-amplifying IPs (Extended 
Data Fig. 3a, e). Altogether, these progenitor driver lines facilitate dis-
secting progenitor diversity and tracking the developmental trajecto-
ries of PyNs from their lineage origin to circuit organization.
Targeting PyN subpopulations
We generated driver lines targeting PyN subpopulations and charac-
terized these in comparison to existing lines where feasible (Fig. 2, 
Extended Data Table 1, Extended Data Fig. 4, Supplementary Tables 1, 
2). These tamoxifen-inducible drivers confer temporal control and 
dose-dependent labelling and manipulation from individual cells to 
dense populations.
IT drivers
IT PyNs constitute the largest top-level class and mediate intracortical 
and corticostriatal communication streams1,19–21. Cux1 and Cux2 are pre-
dominantly expressed in supragranular IT PyNs and their progenitors22,23. 
In our Cux1-CreER;Ai14 mice, postnatal tamoxifen induction prominently 
labelled L2–L4 PyNs dorsal to the rhinal fissure as well as a set of hippocam-
pal PyNs, recapitulating the endogenous pattern (Fig. 2a, Extended Data 
Fig. 4, Supplementary Video 1). Anterograde tracing revealed that PyNsCux1 
in somatosensory barrel cortex (SSp-bfd or SSp) projected predominantly 
to the ipsi- and contralateral cortex, with only very minor branches in the 
striatum (Fig. 3a, d, Extended Data Fig. 7, Supplementary Video 2). Com-
pared with existing IT drivers (Extended Data Figs. 4, 5, Supplementary 
Tables 1, 2), Cux1-CreER is unique in targeting predominantly cortex- but 
not striatum-projecting IT subpopulations.
The supragranular layers comprise diverse IT types20, but only a few 
L2/3 drivers have been reported so far24 and none distinguish L2 versus 
L3 PyNs. We used a lineage and birth dating approach to dissect L2/3 
PyNs. In our Tbr2-CreER driver targeting IPs, tamoxifen induction at 
E16.5 and E17.5 specifically labelled PyNs in L2/3 and L2, respectively 
(Fig. 2c, d). Combined with the CreER to Flp conversion strategy that 
converts lineage and birth timing signals to permanent Flp expression13, 
this approach enables adeno-associated virus (AAV) manipulation of 
L2 and L3 IT neurons.
The plexin D1–semaphorin 3E receptor–ligand system has been impli-
cated in axon guidance and synapse specification25,26. In developing 
and mature cortex, Plxnd1 (encoding plexin D1) is expressed in large 
sets of IT PyNs10. Plxnd1-CreER and Plxnd1-Flp driver lines recapitu-
lated endogenous expression and labelled projection neurons in the 
cerebral cortex, hippocampus, amygdala and striatum (Figs. 2b, 4e, 
Extended Data Figs. 4, 5a, Supplementary Tables 3, 4, Supplementary 
Videos 3, 4); in the neocortex, L5A and L2/3 IT PyNsPlxnd1 were labelled 
(Fig. 2b, Extended Data Fig. 6a–c). As Plxnd1 is also expressed in vascu-
lar cells, we bred Plxnd1-CreER mice with the neuron-specific reporter 
Snap25-LSL-EGFP to selectively label Plxnd1+PyNs (PyNsPlxnd1; Fig. 2b). 
Anterograde tracing from SSp-bfd revealed that PyNsPlxnd1 project to 
ipsi- and contralateral cortical and striatal regions (Fig. 3a, d, Extended 
Data Fig. 7a–c, f, Supplementary Tables 5–7, Supplementary Video 5). 
Thus, Plxnd1 drivers confer access to this major IT subpopulation and 
to Plxnd1+ subpopulations in the striatum and amygdala.
PT drivers
After early expression in a subset of dorsal pallial progenitors, Fezf2 
becomes restricted to postmitotic L5/6 corticofugal PyNs, with higher 
levels in L5B PT neurons and lower levels in a subset of CT neurons10,27. 
At postnatal stages, Fezf2 drivers labelled projection neurons in the 
cerebral cortex, hippocampus, amygdala, and olfactory bulb (Extended 
Data Fig. 4, Supplementary Table 4, Supplementary Video 6). Within 
the neocortex, PyNsFezf2 reside predominantly in L5B and to a lesser 
extent in L6 (Fig. 2e, 1, Extended Data Figs. 4a, d, 6d–f); PyNsFezf2 are 
absent below the rhinal fissure (Supplementary Table 4, Supplemen-
tary Video 6). Anterograde tracing of PyNsFezf2 in SSp-bfd revealed pro-
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Fig. 2 | Genetic targeting of PyN subpopulations. a–j, Driver line 
recombination patterns visualized through reporter expression (green; 
background autofluorescence, red). First row, coronal hemisections. TM, 
tamoxifen. a–d, Second row, IT drivers targeting laminar subsets in L2–L5a of 
somatosensory barrel cortex (SSp-bfd), which project axons across the corpus 
callosum (Cc) (third row) and to the striatum (Str) (bottom row). Cux1 and 
Plxnd1 drivers also label subsets of medium spiny neurons in the striatum 
(arrowheads). E16.5 and E17.5 tamoxifen induction of Tbr2-CreER label L2/3 and 
L2 PyNs, respectively. e–g, Second row, PT drivers label L5B PyNs, which 
project to numerous subcortical targets, including the thalamus (Thal) (third 
row) and spinal cord (corticospinal tract; CST) (bottom row). h–j, Second row, 
CT drivers label L6 PyNs, sending axons mainly to different nuclei in the 
thalamus (third row). Tamoxifen induction times are indicated in the first row. 
The reporter allele was Ai14, except for Plxnd1-CreER (Snap25-LSL-EGFP) and 
Foxp2 (systemic injection of AAV9-CAG-DIO-EGFP). White matter (Wm). Scale 
bars, 100 µm (bottom (CST) panel in g); 1 mm (hemisection in j, which applies 
to the entire row); 200 µm (all other scale bars). Cell bodies are indicated by 
arrowheads and axons by arrows.
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vibrissal secondary motor area (MOs)) and subcortical regions includ-
ing the striatum, thalamic ventral posteromedial nucleus of the thal-
amus (VPM) and posterior complex of the thalamus (PO), anterior 
pretectal nucleus, ipsilateral superior colliculus (iSC), pontine nucleus, 
corticospinal tract (CST) and contralateral spinal trigeminal nucleus 
(cSp5) (Fig. 3b, e, Extended Data Figs. 7a, b, d, f, 8f–r, Supplementary 
Tables 5, 6, Supplementary Video 7).
We further generated several lines targeting finer PT subpopula-
tions. In Adcyap1- and Tcerg1l-CreER drivers, late embryonic induction 
labelled L5B subpopulations that project only to ipsilateral cortical 
targets and to a subset of targets innervated by PyNFezf2 (Figs. 2f, g, 3b, e, 
Extended Data Figs. 4, 6d–f, 7a, b, d, f, Supplementary Tables 4–6, Sup-
plementary Videos 8–11). In Sema3e-CreER (ref. 28), postnatal induction 
labelled a subset of L5B PyNs that project to more-restricted subcortical 
areas, namely higher-order thalamic nucleus POm and pontine nucleus 
(Extended Data Figs. 4d, 8a–e, Supplementary Tables 4, 5, Supplemen-
tary Video 12). Together, the new set of PT drivers will enable a finer hier-
archical dissection of molecularly and anatomically defined PT types.
CT drivers
Tbr1 is expressed in postmitotic L6 CT neurons and represses the 
expression of Fezf2 and Ctip2 (also known as Bcl11b) to suppress the 
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Fezf2 Foxp2 Tle4Tbr1Adcyap1 Tcerg1l
Fig. 3 | Projection patterns of PyN subpopulations in SSp-bfd cortex.  
a–c, Images at SSp-bfd injection site (inj site) (first row, arrowhead) and 
selected subcortical projection targets for eight driver lines: EGFP expression 
from Cre-activated viral vector (green) and background autofluorescence 
(red). Tamoxifen induction time points are indicated below each gene name. 
Arrows indicate axons. a, IT drivers project to the cortex and striatum. Note the 
near absence of projection to the striatum for the Cux1 driver. b, PT drivers 
project to many corticofugal targets, including the brainstem and spinal cord. 
c, CT drivers project predominantly to the thalamus. d–f, Schematics of main 
projection targets for each PyN subset generated in this study. d, IT drivers.  
e, PT drivers. f, CT drivers. Ipsilateral secondary motor area (iMOs); 
contralateral primary somatosensory area (cSSp); secondary somatosensory 
area (SSs); auditory areas (AUD); visual areas (VIS); retrosplenial area (RSP); 
temporal association areas (TEa); ectorhinal area (ECT); reticular nucleus of  
the thalamus (RT); ventral anterior–lateral complex of the thalamus (VAL); 
ventral posteromedial complex of the thalamus (VPM); ventral posterior–
lateral complex of the thalamus (VPL); submedial nucleus of the thalamus 
(SMT); posterior complex of the thalamus (PO); substantia nigra, reticular 
part (SNr); superior colliculus (SC); caudoputamen (CP); mediodorsal nucleus 
of the thalamus (MD); paracentral nucleus (PCN); central medial nucleus of the 
thalamus (CM); parafascicular nucleus (PF); globus pallidus, external segment 
(GPe); lateral dorsal nucleus of the thalamus (LD); central lateral nucleus of the 
thalamus (CL); anterior pretectal nucleus (APN); ventral medial nucleus of the 
thalamus (VM); zona incerta (ZI); midbrain reticular nucleus (MRN); 
periaqueductal gray (PAG); pontine gray (PG); gigantocellular reticular nucleus 
(GRN); tegmental reticular nucleus (TRN); medullary reticular nucleus 
(MDRN); intermediate reticular nucleus (IRN); and parvicellular reticular 
nucleus (PARN).  Scale bars, 1 mm (first row, in c); 200 µm (second to eighth 
rows, in c (for each respective row); 100 µm (CST panel in c, which applies to  
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Fig. 4 | Combinatorial targeting of IT subtypes by lineage, birth time and 
anatomy. a, Strategy for combinatorial labelling of PyNPlxnd1 subtypes. In a 
Tbr2-CreER;Plxnd1-Flp;Ai65 mouse, tamoxifen inductions at successive 
embryonic times label deep or more superficial PyNPlxnd1 subsets born 
sequentially from intermediate progenitors. b–d, Laminar subsets born at 
E13.5 (b), E15.5 (c) and E17.5 (d). e, The overall population is labelled in a 
Plxnd1-Flp;R26-FSF-tdTom mouse for comparison. The bottom panels  
in b–e show high-magnification images of the boxed regions in the top panels. 
f, In Tbr2-CreER;Plxnd1-Flp;dual-tTA mice, E13.5 or E17.5 tamoxifen inductions 
activate tTA expression in L5A or L2 PyNsPlxnd1, respectively, and 
AAV-TRE3g-memb-mRuby2 anterograde injection in SSp-bfd reveals the 
projection pattern of each laminar subset. g, n, Coronal sections display the 
injection site and several major projection targets. g–m, Anterograde tracing 
from E13.5-born L5A PyNsPlxnd1 in SSp-bfd, with images (h–m) of projection 
targets in several ipsi- and contralateral regions. n–t, Anterograde tracing from 
E17.5-born L2 PyNsPlxnd1 in SSp-bfd, with images (o–s) of projection targets in 
several ipsi- and contralateral regions. The bottom panels in l, m, s and t show 
high-magnification images of the boxed regions in the top panels. The higher 
magnification of cSSp (l, s; bottom) and iMOs (m, t; bottom) display laminar 
axon termination differences between L5A and L2 PyNsPlxnd1. u, Schematics 
comparing E13.5-born L5A (left) and E17.5-born L2 (middle) PyNPlxnd1 projection 
patterns; note differences in the strength of several contralateral targets and in 
the laminar pattern of axon termination (right). Arrowheads indicate cell body 
positions; arrows indicate axons. Contralateral temporal association area 
(cTEa); ipsilateral striatum (iStr); contralateral striatum (cStr); white matter 
(Wm). Scale bars: 1 mm (b–e (top panels), g, n); 200 µm (b–e (bottom panels)); 
50 µm (h–t (including top panels in l, m, s, t)); 5 µm (l, m, s, t (bottom panels)).
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L6 CT neurons densely, with sparse labelling in L2/3, cerebral nuclei, 
hippocampus, piriform cortex and amygdala (Fig. 2h, Extended Data 
Fig. 4a–c, Supplementary Table 4, Supplementary Video 13). PyNsTbr1 
from SSp-bfd projected to multiple thalamic targets, including primary 
and higher order nuclei, as well as reticular nucleus of the thalamus 
(Fig. 3c, f, Supplementary Tables 5, 6, Supplementary Video 14). Consist-
ent with a study showing that some PyNsTbr1 project to the contralateral 
cortex30, we found labelling in the corpus callosum (Extended Data 
Fig. 6). It remains to be determined whether PyNsTbr1 with contralateral 
projections (Fig. 3f) represent a distinct type.
Tle4 is a transcription corepressor that is expressed in a subset of CT 
PyNs31,32. Our Tle4-CreER driver specifically labelled L6 CT PyNs across 
the cortex (Fig. 2i, Extended Data Figs. 4, 6d–f, Supplementary Table 4, 
Supplementary Video 15). Tle4 is also expressed in medium spiny neu-
rons of the striatum, olfactory bulb, hypothalamus, iSC, cerebellum and 
septum (Extended Data Fig. 4c, Supplementary Table 4, Supplementary 
Video 15). PyNsTle4 in SSp-bfd specifically projected to first-order tha-
lamic VPM and reticular nucleus of the thalamus (Fig. 3c, f, Extended 
Data Fig. 7a, b, e, f, Supplementary Table 4, Supplementary Video 16).
Foxp2 is expressed in many CT neurons from the postmitotic stage 
to the mature cortex33–35. In adult Foxp2-IRES-Cre mice36, systemic injec-
tion of Cre-dependent AAV9-DIO-GFP specifically labelled L6 PyNs; 
Foxp2+ cells were also found in the striatum, thalamus, hypothala-
mus, midbrain, cerebellum and inferior olive (Fig. 2j, Extended Data 
Fig. 4a–c, Supplementary Table 4, Supplementary Video 17). PyNFoxp2 
in SSp-bfd projected to thalamus, tectum and some ipsilateral cortical 
areas (Fig. 3c, f, Supplementary Tables 4, 5, Supplementary Video 18). 
Compared to PyNsTle4, PyNsFoxp2 projected more broadly to the thalamus, 
largely overlapping with PyNTbr1 axons.
To further characterize several PyN driver lines, we performed a 
set of histochemical analyses (Extended Data Fig. 6). PyNs targeted 
in Fezf2, Tcerg1l and Adcyap1 drivers extensively co-labelled with PT 
markers. PyNs targeted in Tle4 and Tbr1 drivers co-labelled with CT 
markers. The laminar patterns and class-specific marker expression 
in these driver lines precisely recapitulated endogenous patterns 
(in situ hybridization data in the Allen Brain Map: Mouse Brain Atlas; 
https://mouse.brain-map.org/search/index), providing further evi-
dence of the reliability and specificity of these driver lines.
Combinatorial targeting of projection types
To further dissect driver-line-defined subpopulations according to 
projection targets, we first used retrograde tracing. Within the PT 
population, retroAAV and fluorogold injections in the spinal cord of 
Fezf2-CreER mice specifically labelled L5B corticospinal PyNs in the sen-
sorimotor cortex (Extend Data Fig. 10a–c, Supplementary Table 6). To 
explore PyNsFezf2 subpopulations jointly defined by projection targets 
and sublaminar position, we used the IS reporter13. Consistent with 
previous findings37, PyNsFezf2 that project to the thalamus and medulla 
resided in the upper and lower sublamina of L5B in the primary motor 
area (MOp), respectively (Extended Data Fig. 9d–f). In SSp-bfd, PyNsFezf2 
with collaterals to the striatum resided in upper L5, those with collater-
als to the superior colliculus or cSp5 resided in the middle and lower 
portion of L5B, and those projecting to thalamic POm resided both in 
middle to lower L5B and in L6 (Extended Data Fig. 9g–h, l–o). We then 
distinguished subsets of L5B PyNsFezf2 according to their expression of 
the calcium-binding protein parvalbumin using Fezf2-CreER;Pv-Flp;IS 
mice that differentially labelled PyNsFezf2+/PV− and PyNsFezf2+/PV+ (in which 
PV represents parvalbumin; this gene is also known as Pvalb) (Extended 
Data Fig. 9i, j). Compared to PyNsFezf2+/PV−, PyNsFezf2+/PV+ exhibited more 
depolarized resting membrane potentials. In addition, we designed 
a strategy (triple trigger) to target PyNsFezf2 jointly defined by a driver 
line, a projection target and a cortical location (Extended Data Fig. 10).
We also used retroAAV to dissect the CT and IT populations. In 
Tle4-CreER;IS mice, retrograde tracing from the thalamic VPM revealed 
two subpopulations of L6 PyNsTle4, one extending apical dendrites to 
the L4/5 border, the other to L1 (Extended Data Fig. 9q), suggesting 
differential inputs. In Plxnd1-CreER mice (Extended Data Fig. 9p, r–w), 
whereas L5A PyNsPlxnd1 projected to both the ipsi- and the contralateral 
striatum, L2/3 PyNsPlxnd1 projected mostly to the ipsilateral striatum.
In addition, consistent with the finding that some PyNsFezf2 extend 
contralateral cortical and striatal projections (Fig. 3e), retrograde chol-
era toxin subunit B (CTB) tracing from the striatum labelled a set of con-
tralateral PyNsFezf2+ at the L5A–L5B border (Extended Data Fig. 11a–e), 
a characteristic IT feature. Indeed, a small set of PyNs at the L5A–L5B 
border co-expressed Fezf2 and Plxnd1 mRNAs; these PyNsFezf2/Plxnd1 
occupied the very top sublayer of the PyNFezf2 population (Extended 
Data Fig. 11f–h), and thus probably contributed to their contralateral 
cortical and striatal projections (Fig. 3a, b, d, e). Single-cell reconstruc-
tion may reveal whether PyNsFezf2/Plxnd1 are typical IT cells or also project 
subcortically and represent an ‘intermediate PT-IT’ type.
Finally, we show highly specific targeting of PyN subtypes by combin-
ing their developmental, molecular and anatomical attributes. PyNsPlxnd1 
localize to L5A, L3 and L2 and project to numerous ipsilateral and con-
tralateral cortical and striatal targets (Figs. 2b, 3a, d, Extended Data 
Figs. 4, 7). We developed a method (Fig. 4a) to dissect PyNPlxnd1 subtypes 
on the basis of the developmental principle that PyN birth order cor-
relates with laminar position and the observation that the majority of IT 
PyNs are generated from IPs17. In Plxnd1-Flp;Tbr2-CreER;Ai65 mice, the 
constitutive Plxnd1-Flp allele marks the whole population (Fig. 4e) and 
the inducible Tbr2-CreER allele enables birth dating (Fig. 4a). Notably, 
tamoxifen induction at E13.5, 15.5 and 17.5 selectively labelled L5Aand 
progressively more superficial PyNsPlxnd1 (Fig. 4b–d). We then bred Plx
nd1-Flp;Tbr2-CreER;dual-tTA mice for anterograde tracing of projec-
tion patterns (Fig. 4f). AAV-TRE3g-mRuby injection into SSp-bfd in 
E13.5- and 17.5-induced mice labelled distinct subtypes of PyNsPlxnd1 with 
different projection patterns. E13.5-born PyNsPlxnd1(E13.5) resided in L5A 
and projected ipsilaterally to multiple cortical areas, contralaterally to 
homotypic SSp-bfd cortex and heterotypic cortical areas, and bilater-
ally to the striatum (Fig. 4g–m, u). By contrast, E17.5-born PyNsPlxnd1(E17.5) 
resided in L2; although they also extended strong projections to ipsi-
lateral cortical and striatal targets and to the homotypic contralateral 
cortex, they had minimal projections to the heterotypic contralateral 
cortex and striatum (Fig. 4n–u). These birth-dated PyNPlxnd1 subsets 
further differed in their axon termination patterns within a cortical 
target area. Whereas PyNPlxnd1(E13.5) axons terminated throughout the 
thickness of L1 and L2/3, with few axon branches in L5A, PyNPlxnd1(E17.5) 
axons terminated strongly in L2/3 and L5A, with few branches in L1 
(Fig. 4l–m, s–u). Thus, even within the same target areas, birth-dated 
PyNsPlxnd1 may preferentially select different postsynaptic cell types 
and/or subcellular compartments.
Discussion
Together with previous resources24,38,39, the PyN driver lines we present 
here provide much improved specificity, coverage and robustness for 
a systematic dissection of PyN organization from broad subclasses to 
finer types. By focusing on driver lines that recapitulate the expression 
of key transcription factors and effector genes that are implicated in 
specification and differentiation, these tools will enable the dissection 
and fate-mapping of biologically significant subpopulations of PyNs 
through their inherent developmental, anatomical and physiologi-
cal properties; that is, ‘carving nature at its joints’. The precision and 
reliability of these drivers also allows the combinatorial targeting of 
finer projection types through the intersection of molecular, devel-
opmental and anatomical properties. The inducibility of driver lines 
enhances the specificity and flexibility of cell targeting, manipulation 
and fate-mapping. Inducibility also allows control over the density 
of labelling and manipulation, from dense coverage to single-cell 
analysis—the ultimate resolution for clarifying the stereotypical and 
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variable features of neurons within marker-defined subpopulations40–42. 
Temporal control allows gene manipulations at different develop-
mental stages to discover the cellular and molecular mechanisms of 
circuit development and function. Together, these tools and strategies 
establish a roadmap for dissecting the hierarchical organization of 
PyN types on the basis of their inherent biology. The incorporation of 
recently developed enhancer AAVs43 with these driver lines may further 
increase the specificity, ease and throughput of cell-type access.
Several transcription factors used in this study (for example, Cux1, 
Fezf2, Tbr1, Tbr2 and Foxp2) continue to evolve and diverge in primates44 
and are implicated in developmental disorders such as autism23,35. Our 
transcription factor driver lines provide handles to track the develop-
mental trajectories of PyN subpopulations in cortical circuit assembly, 
with implications in the cross-species evolution of PyNs and for deci-
phering the genetic architecture of neurodevelopmental disorders.
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No statistical methods were used to predetermine sample size. The 
experiments were not randomized and the investigators were not 
blinded to allocation during experiments and outcome assessment.
Generation of knock-in mouse lines
Driver and reporter mouse lines listed in Supplementary Table 1 were 
generated using a PCR-based cloning, as described before and below13,45. 
All experimental procedures were approved by the Institutional Animal 
Care and Use Committee (IACUC) of the Cold Spring Harbor Labora-
tory (CSHL) in accordance with NIH guidelines. Mouse knock-in driver 
lines are deposited at The Jackson Laboratory for wide distribution. 
Knock-in mouse lines were generated by inserting a 2A-CreER or 2A-Flp 
cassette in-frame before the STOP codon of the targeted gene. Tar-
geting vectors were generated using a PCR-based cloning approach 
as described before. In brief, for each gene of interest, two partially 
overlapping BAC clones from the RPCI-23&24 library (made from 
C57BL/b mice) were chosen from the Mouse Genome Browser. The 
5′ and 3′ homology arms were PCR-amplified (2–5 kb upstream and 
downstream, respectively) using the BAC DNA as template and cloned 
into a building vector to flank the 2A-CreERT2 or 2A-Flp expressing cas-
sette as described47. These targeting vectors were purified and tested 
for integrity by enzyme restriction and PCR sequencing. Linearized 
targeting vectors were electroporated into a 129SVj/B6 hybrid embry-
onic stem (ES) cell line (v6.5). ES clones were first screened by PCR 
and then confirmed by Southern blotting using appropriate probes. 
DIG-labelled Southern probes were generated by PCR, subcloned and 
tested on wild-type genomic DNA to verify that they give clear and 
expected results. Positive v6.5 ES cell clones were used for tetraploid 
complementation to obtain male heterozygous mice following stand-
ard procedures. The F0 males were bred with reporter lines (Supple-
mentary Tables 1, 3, 4) and induced with tamoxifen at the appropriate 
ages to characterize the resulting genetically targeted recombination 
patterns.
Tamoxifen induction
Tamoxifen (T5648, Sigma) was prepared by dissolving in corn oil 
(20 mg ml−1) and applying a sonication pulse for 60 s, followed by 
constant rotation overnight at 37 °C. Embryonic inductions for most 
knock-in lines were done in the Swiss-Webster background; induc-
tions for Tis21-CreER, Fezf2-Flp intersection experiments were done 
in the C57BL6 background. E0.5 was established as noon on the day 
of vaginal plug and tamoxifen was administered to pregnant mothers 
by gavage at a dose varying from 2–100 mg kg−1 at the appropriate 
age. For embryonic collection (12–24 h pulse-chase experiments), a 
dose of 2mg kg−1 was administered to pregnant dams via oral gavage. 
For postnatal induction, a 100–200 mg kg−1 dose was administered by 
intraperitoneal injection at the appropriate age.
Immunohistochemistry
Postnatal and adult mice were anaesthetized (using Avertin) and intra-
cardially perfused with saline followed by 4% paraformaldehyde (PFA) 
in 0.1 M PB. After overnight post-fixation at 4 °C, brains were rinsed 
three times and sectioned at a 50–75-µm thickness with a Leica 1000s 
vibratome. Embryonic brains were collected in PBS and fixed in 4% PFA 
for 4 h at room temperature, rinsed three times with PBS, dehydrated in 
30% sucrose-PBS, frozen in OCT compound and cut by cryostat (Leica, 
CM3050S) in 20–50-µm coronal sections. Early postnatal pups were 
anaesthetized using cold shock on ice and intracardially perfused with 
4% PFA in PBS. Post-fixation was performed similarly to older mice. 
Postnatal mice aged 1–2 months were anaesthetized using Avertin and 
intracardially perfused with saline followed by 4% PFA in PBS; brains 
were post-fixed in 4% PFA overnight at 4 °C and subsequently rinsed 
three times, embedded in 3% agarose-PBS and cut to a 50–100-µm 
thickness using a vibrating microtome (Leica, VT100S). Sections were 
placed in blocking solution containing 10% normal goat serum (NGS) 
and 0.1% Triton-X100 in PBS1X for 1 h, then incubated overnight at 4 °C 
with primary antibodies diluted in blocking solution. Sections were 
rinsed three times in PBS and incubated for 1 h at room temperature 
with corresponding secondary antibodies (1:500, Life Technologies). 
Sections were washed three times with PBS and incubated with DAPI 
for 5 min (1:5,000 in PBS, Life Technologies, 33342) to stain nuclei. 
Sections were dry-mounted on slides using Vectashield (Vector Labs, 
H1000) or Fluoromount (Sigma, F4680) mounting medium.
To perform molecular characterization of GeneX-CreER mouse lines, 
we stained 40-µm vibratome sections for CUX1 and CTIP2, that were 
imaged in a Nikon Eclipse 90i fluorescence microscope. Focusing on 
the somatosensory cortex, we counted tdTomato+ cells in a column 
of around 300-µm width and determined their relative position along 
the dorso-ventral axis that goes from the ventricular surface (0) to the 
pia (100%). As a reference, CTIP2+ and CUX1+ regions were plotted as 
green and blue bars, where the upper limits correspond to the mean 
relative position of the dorsal-most positive cells, and the lower limits 
correspond to the mean relative position of the ventral-most positive 
cells. Grey areas in histograms correspond to the s.d. of those limits. The 
frequency of tdTomato+ cells along the dorso-ventral axis was plotted 
in a histogram with a bin width of 5%. Number of cells: Fezf2-CreER, 2,781 
cells; Tcerg1l-CreER, 185 cells; Adcyap1-CreER, 54 cells; Tle4-CreER, 2,737 
cells; Lhx2-CreER, 1,380 cells; Plexind1-CreER, 809 cells; Cux1-CreER, 
2,296 cells; Tbr1-CreER, 3,572 cells; Tbr2-CreER tamoxifen E16.5, 1,273 
cells; Tbr2-CreER tamoxifen E17.5, 1,871 cells. For each line we quantified 
at least four sections from two embryos. Differences in cell numbers 
are due to differences in labelling density.
For colocalization determination, we obtained confocal z-stacks cen-
tred in layer 5 or 6 of the somatosensory cortex, of 320 × 320 × 40 µm3 
volumes. For all tdTomato+ cells in the volume, we manually determined 
whether they were also positive for the desired markers by looking in 
individual z-planes. The percentage of positive cells was calculated for 
each area. Average number of tdTomato+ cells quantified per staining: 
Fezf2-CreER, 314 cells in layer 5 and 472 in layer 6; Tcerg1l-CreER, 162 
cells; Adcyap-CreER, 20 cells; Tle4-CreER, 157 cells in layer 5 and 1,081 
in layer 6; Lhx2-CreER, 294 cells; Plexind1-CreER, 468 cells in layers 4 
and 5a; Cux1-CreER, 761 cells; Tbr1-CreER, 858 cells; Tbr2-CreER, 1,380 
cells. For each line we quantified at least four sections from at least 
two embryos. Differences in cell numbers are due to differences in 
labelling density.
Antibodies
Anti-GFP (1:1,000, Aves, GFP-1020), anti-RFP (1:1,000, Rockland Phar-
maceuticals, 600-401-379), anti-mCherry (1:500, OriGene AB0081-
500), anti-mKATE2 for Brainbow 3.0 (a gift from D. Cai), anti-SATB2 
(1:20, Abcam ab51502), anti-CTIP2 (1:100, Abcam 18465), anti-CUX1 
(1:100, SantaCruz 13024), anti-LDB2 (1:200, Proteintech 118731-AP), 
anti-FOG2 (1:500, SantaCruz m-247), anti-LHX2 (1:250, Millipore-Sigma 
ABE1402) and anti-TLE4 (1:300, Santa Cruz sc-365406) were used.
Validation of PyN driver lines
ViewRNA tissue Assay (Thermo Fisher Scientific) fluorescent in situ 
hybridization (FISH) was carried out as per the manufacturer’s instruc-
tions on genetically identified PyNs expressing H2bGFP nuclear 
reporter (GeneX-CreER;LSL-H2bGFP) to validate the expression of 
PyN mRNA within Cre-recombinase dependent H2bGFP expressing 
cells in adult tissue (p24). Antibody validation with Cre-recombinase 
dependent reporter (GeneX-CreER;Ai14) was also used as it was 
available for use in adult tissue. For both FISH and antibody valida-
tion experiments, the percentage of total recombinase-dependent 
reporter-positive cells co-expressing PyN driver transcript or antibody 
was quantified.
Viral injection and analysis
Stereotaxic viral injection. Adult mice were anaesthetized by inhala-
tion of 2% isofluorane delivered with a constant air flow (0.4 l min−1). 
Ketoprofen (5 mg kg−1) and dexamethasone (0.5 mg kg−1) were admin-
istered subcutaneously as preemptive analgesia and to prevent brain 
oedema, respectively, before surgery, and lidocaine (2–4 mg kg−1) was 
applied intra-incisionally. Mice were mounted in a stereotaxic head-
frame (Kopf Instruments, 940 series or Leica Biosystems, Angle Two). 
Stereotactic coordinates were identified (Supplementary Table 5). An 
incision was made over the scalp, a small burr hole drilled in the skull 
and brain surface exposed. Injections were performed according to the 
strategies delineated in Supplementary Table 5. A pulled glass pipette 
tip of 20–30 µm containing the viral suspension was lowered into the 
brain; a 300–400 nl volume was delivered at a rate of 30 nl min−1 using 
a Picospritzer (General Valve Corp); the pipette remained in place for 
10 min preventing backflow, prior to retraction, after which the inci-
sion was closed with 5/0 nylon suture thread (Ethilon Nylon Suture, 
Ethicon) or Tissueglue (3M Vetbond), and mice were kept warm on a 
heating pad until complete recovery.
Systemic AAV injection. Foxp2-IRES-Cre mice were injected through 
the lateral tail vein at 4 weeks of age with a 100 µl total volume of 
AAV9-CAG-DIO-EGFP (UNC Viral Core) diluted in PBS (5 × 1011 vg per 
mouse). Three weeks after injection, mice were transcardially perfused 
with 0.9% saline, followed by ice-cold 4% PFA in PBS, and processed for 
serial two-photon (STP) tomography.
Viruses
AAVs serotype 8, 9, DJ PHP.eB or rAAV2-retro (retroAAV) packaged by 
commercial vector core facilities (UNC Vector Core, ETH Zurich, Bio-
hippo, Penn, Addgene) were used as listed in Supplementary Table 5. In 
brief, for cell-type-specific anterograde tracing, we used either Cre- or 
Flp-dependent or tTA-activated AAVs combined with the appropriate 
reporter mouse lines28 (Supplementary Table 7), or dual-tTA (Fig. 4 
and Extended Data Fig. 10) to express EGFP, EYFP or mRuby2 in labelled 
axons. retroAAV-Flp was used to infect axons at their terminals46 in 
target brain structures to label PyNs retrogradely according to the 
experiments detailed in Supplementary Table 5.
Microscopy and image analysis
Imaging was performed using Zeiss LSM 780 or 710 confocal micro-
scopes, Nikon Eclipse 90i or Zeiss Axioimager M2 fluorescence micro-
scopes, or whole-brain STP tomography (detailed below). Imaging from 
serially mounted sections was performed on a Zeiss LSM 780 or 710 
confocal microscope (CSHL St. Giles Advanced Microscopy Center) 
and Nikon Eclipse 90i fluorescence microscope, using objectives ×63 
and ×5 for embryonic tissue, and ×20 for adult tissue, as well as ×5 on 
a Zeiss Axioimager M2 System equipped with MBF Neurolucida Soft-
ware (MBF). Quantification and image analysis was performed using 
Image J/FIJI software. Statistics and plotting of graphs were done using 
GraphPad Prism 7 and Microsoft Excel 2010.
Twenty-four-hour pulse-chase embryonic experiments. For 
24-hour pulse-chase embryonic experiments (Fig. 1, Extended Data 
Fig. 1), high-magnification insets are not maximum intensity projec-
tions. To observe the morphology of RGs, only a few sections from 
the z-plane in low-magnification images have been projected in the 
high-magnification images.
Quantification and statistics related to progenitor fate-mapping. 
Quantification for top panels in Fig. 1h, Extended Data Fig. 2m–o 
(n = 5–6 from two litters): mean values, number of progenitors ± s.e.m. 
*P < 0.05 (compared with bin M, RGsLhx2+), #P < 0.05 (compared with bin 
M, RGsFezf2+), one-way ANOVA, Tukey’s post-hoc test. †P < 0.05 (compared 
with RGsLhx2+ for corresponding bins), unpaired Student’s t-test. Quan-
tification for bottom panels in Fig. 1h, Extended Data Fig. 2m–o (n = 3 
from two litters): mean values for percentage total PyNs (S1)  ± s.e.m. 
*P < 0.05 (compared with PyNsLhx2+). Quantification for Fig. 1k, Extended 
Data Fig 2t: top panel: (n = 3 from two litters): mean values, number 
of progenitors ± s.e.m. *P < 0.0001 (compared with RGsLhx2+Fezf2−), un-
paired Student’s t-test. Bottom panel (n = 3 from two litters): mean 
values, number of progenitors ± s.e.m. *P < 0.05 (compared with rostral 
RGsLhx2+Fezf2−), #P < 0.05 (compared with rostral RGsLhx2+Fezf2+), one-way 
ANOVA, Tukey’s post-hoc test. †P < 0.05 (compared with RGsLhx2+/Fezf2− for 
corresponding regions), unpaired Student’s t-test.
Target-specific cell depth measurement. Cell depth analysis for 
retrogradely labelled projection-specific genetically identified PyNs 
(GeneX-CreER) were obtained using 5× MBF fluorescent widefield im-
ages of 65-µm thick coronal sections in MO and SSp-bfd. MO cell depths 
are presented in micrometres owing to the absence of a defined white 
matter border in frontal cortical areas and SSp-bfd depth ratio measure-
ments were normalized to the distance from pia to white matter. For 
each condition we quantified at least four sections taken from two mice.
Whole-brain STP tomography and image analysis
Perfused and post-fixed brains from adult mice were embedded in 
oxidized agarose and imaged with TissueCyte 1000 (Tissuevision) as 
described48,49. We used the whole-brain STP tomography pipeline previ-
ously described48,49. Perfused and post-fixed brains from adult mice, 
prepared as described above, were embedded in 4% oxidized-agarose 
in 0.05 M PB, cross-linked in 0.2% sodium borohydrate solution (in 
0.05 M sodium borate buffer, pH 9.0–9.5).The entire brain was imaged 
in coronal sections with a 20× Olympus XLUMPLFLN20XW lens (NA 1.0) 
on a TissueCyte 1000 (Tissuevision) with a Chameleon Ultrafast-2 
Ti:Sapphire laser (Coherent). EGFP/EYFP or tdTomato signals were 
excited at 910 nm or 920 nm, respectively. Whole-brain image sets were 
acquired as series of 12 (x) × 16 (y) tiles with 1 µm × 1 µm sampling for 
230–270 z sections with a 50-µm z-step size. Images were collected by 
two PMTs (PMT, Hamamatsu, R3896), for signal and autofluorescent 
background, using a 560-nm dichroic mirror (Chroma, T560LPXR) and 
band-pass filters (Semrock FF01-680/SP-25). The image tiles were cor-
rected to remove illumination artifacts along the edges and stitched as 
a grid sequence47,49. Image processing was completed using ImageJ/FIJI 
and Adobe/Photoshop software with linear level and nonlinear curve 
adjustments applied only to entire images.
Cell body detection from whole-brain STP data. PyN somata were au-
tomatically detected from cell-type specific reporter lines (R26-LSL-GFP 
or Ai14) by a convolutional network trained as described previously48. 
Detected PyN soma coordinates were overlaid on a mask for cortical 
depth, as described48.
Axon detection from whole-brain STP data. For axon projection 
mapping, PyN axon signal based on cell-type-specific viral expression 
of EGFP or EYFP was filtered by applying a square root transformation, 
histogram matching to the original image, and median and Gaussian 
filtering using Fiji/ImageJ software50 so as to maximize signal detection 
while minimizing background auto-fluorescence, as described before51. 
A normalized subtraction of the autofluorescent background channel 
was applied and the resulting thresholded images were converted to 
binary maps. Three-dimensional rendering was performed on the basis 
of binarized axon projections and surfaces were determined based on 
the binary images using Imaris software (Bitplane). Projections were 
quantified as the fraction of pixels in each brain structure relative to 
each whole projection.
Axon projection cartoon diagrams from whole-brain STP data. To gen-
erate cartoons of axon projections for a given driver line, axon detection 
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outputs from all individual experiments were compared (sorting the 
values from high to low), and analysed side-by-side with low-resolution 
image stacks (and the CCFv3 registered to the low-resolution dataset for 
brain area definition) to get a general picture of the injection, as well as 
high-resolution images for specific brain areas.
Registration of whole-brain STP image datasets. Registration of 
brain-wide datasets to the Allen reference Common Coordinate Frame-
work (CCF) version 3 was performed by 3D affine registration followed 
by a 3D B-spline registration using Elastix software52, according to es-
tablished parameters52. For cortical depth and axon projection analysis, 
we registered the CCFv3 to each dataset so as to report cells detected 
and pixels from axon segmentation in each brain structure without 
warping the imaging channel.
In vitro electrophysiology
Brain slice preparation. Mice (>P30) were anaesthetized with iso-
flurane, decapitated, brains dissected out and rapidly immersed in 
ice-cold, oxygenated, artificial cerebrospinal fluid (section ACSF: 
110 mM choline-Cl, 2.5 mM KCl, 4 mM MgSO4, 1 mM CaCl2, 1.25 mM 
NaH2PO4, 26 mM NaHCO3, 11 mM d-glucose, 10 mM Na ascorbate, 3.1 Na 
pyruvate, pH 7.35, 300 mOsm) for 1 min. Coronal cortical slices contain-
ing somatomotor cortex were sectioned at a 300-µm thickness using 
a vibratome (HM 650 V; Microm) at 1–2 °C and incubated with oxygen-
ated ACSF (working ACSF; 124 mM NaCl, 2.5 mM KCl, 2 mM MgSO4, 
2 mM CaCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3, 11 mM d-glucose, 
pH 7.35, 300 mOsm) at 34 °C for 30 min, and subsequently transferred 
to ACSF at room temperature (25 °C) for more than 30 min before use. 
Whole-cell patch recordings were directed to the somatosensory and 
motor cortex, and the subcortical whiter matter and corpus callosum 
served as primary landmarks according to the atlas (Paxinos and Wat-
son Mouse Brain in Stereotaxic Coordinates, 3rd edition).
Patch-clamp recording in brain slices. Patch pipettes were pulled 
from borosilicate glass capillaries with filament (1.2 mm outer diameter 
and 0.69 mm inner diameter; Warner Instruments) with a resistance of 
3–6 MΩ. The pipette recording solution consisted of 130 mM potassium 
gluconate, 15 mM KCl, 10 mM sodium phosphocreatine, 10 mM HEPES, 
4 mM ATP·Mg, 0.3 mM GTP and 0.3 mM EGTA (pH 7.3 adjusted with 
KOH, 300 mOsm). Dual or triple whole-cell recordings from tdTomato+ 
and EGFP+ PyNs were made with Axopatch 700B amplifiers (Molecular 
Devices) using an upright microscope (Olympus, BX51) equipped with 
infrared-differential interference contrast optics (IR-DIC) and a fluo-
rescence excitation source. Both IR-DIC and fluorescence images were 
captured with a digital camera (Microfire, Optronics). All recordings 
were performed at 33–34 °C with the chamber perfused with oxygen-
ated working ACSF.
Recordings were made with two MultiClamp 700B amplifiers (Molec-
ular Devices). The membrane potential was maintained at −75 mV in 
the voltage clamping mode and zero holding current in the current 
clamping mode, without the correction of junction potential. Signals 
were recorded and filtered at 2 kHz, digitalized at 20 kHz (DIGIDATA 
1322A, Molecular Devices) and further analysed using the pClamp 10.3 
software (Molecular Devices) for intrinsic properties.
Reporting summary
Further information on research design is available in the Nature 
Research Reporting Summary linked to this paper.
Data availability
Raw and stitched whole-brain STP imaging data are available from the 
BICCN Brain Image Library (BIL) (http://www.brainimagelibrary.org/
download.html) at the Pittsburgh Supercomputing Center. Antero-
grade projection and cell distribution datasets can be visualized on 
the Mouse Brain architecture website (http://brainarchitecture.org/
cell-type/projection and http://brainarchitecture.org/cell-type/density, 
respectively) as detailed in Supplementary Tables 4, 5.
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Extended Data Fig. 1 | See next page for caption.
Extended Data Fig. 1 | Fate-mapping using Lhx2 and Fezf2 driver lines.  
a, 24-hour pulse-chase in a E10.5 Lhx2-CreER;Ai14 embryo densely labelled 
RGsLhx2+ throughout the dorsal neuroepithelium, sharply ending at the cortex–
hem boundary (Hm); magnified view shows RGs at different stages of the cell 
cycle, with endfeet (arrow) or dividing somata (arrowhead) at the ventricle wall 
(dashed lines). b, E10.5 RGs generate PyNs across layers in P30 neocortex in 
Lhx2-CreER;RGBow mouse13 (Supplementary Table 1). c, d are duplicated from 
Fig. 1c, d for comparison. e, Same experiment as in a done at E13.5. 
RGsLhx2+remain distributed in a medialhigh-laterallow gradient along the dorsal 
pallium but at a reduced density compared to earlier stages. f, E14.5 
RGsLhx2+generated PyNs with lower density in L5/6, higher density in L2-4, and 
highest density in L4, suggesting more restricted fate potential. g, 24-hour 
pulse-chase in a E10.5 Fezf2-CreER;Ai14 embryo. The spatial extent of RGsFezf2+  
in neuroepithelium is more restricted compared to RGsLhx2+ at this stage; 
magnified view shows RG endfoot (arrow) at the ventricle (dashed lines). Note 
the sparsity of dividing RGs. h, Fate-mapping of E10.5 RGsFezf2+ in a Fezf2-
CreER;RGBow mouse labelled PyN progeny across all cortical layers. i, j are 
duplicated from Fig. 1e, f for comparison. k, Same experiment as in g done at 
E13.5. Only sparse RGsFezf2+ remain in medial pallium at this time, when 
Fezf2expression shifts to postmitotic PyNs (arrowheads); magnified view 
shows a remaining RG (arrow) at the ventricle wall (dashed line). l, Fate-
mapping at E18.5 in Fezf2-CreER;RGBow labelled only L5b/L6 PyNs in mature 
cortex. m, Upper panel, quantification of E10.5 RGsLhx2+(red) (in a) versus 
RGsFezf2+ (pink) (in g) distributed across the cortical primordium, divided into 
medial (M), dorsal (D) and lateral (L) bins of equal length. Lower panel, laminar 
distribution of PyNs generated by RGsLhx2+ (red) or RGsFezf2+(pink) at E10.5, 
shown as percentage of total PyNs in S1 barrel cortex. n, Same quantification of 
RGsLhx2+ and RGsFezf2+as in m except done at E12.5. o, Same quantification of 
RGsLhx2+ and RGsFezf2+as in m except done at E13.5 (upper panel), and the laminar 
distribution of their PyN progeny fate-mapped at E14.5 (for RGsLhx2+) and E18.5 
(for RGsFezf2+) (lower panel). p, Fate-mapping E12.5 RGsLhx2+ to mature cortex 
labelled PyN progeny that are SATB2+ (IT class, 66.8%) as well as SATB2- (non-IT 
class, 33.2%). Of these, 72.8% of L2-4 (UL; 728 of 1,000 cells) and 60.8% of L5-6 
(DL; 304 of 500 cells; n=3 brains from 2 litters) PyNs are of IT-type.  
q, P5 tamoxifen induction in Lhx2-CreER;Ai14 shows dense labelling of L2-4 
PyNs and sparse labelling in L5/6 in P28 cortex (Left panel) Most labelled PyNs 
are of the IT class expressing SATB2 (middle and right panels; UL, 92.4% - 924 of 
1,000 cells; DL, 90.5%–181 of 200 cells; n=3 brains from 2 litters). r, P15 
tamoxifen induction in Lhx2-CreER;Ai14. (Upper) Quantification in SSp-bfd 
shows 58% cells are glia (Mean values for number of cells in SSp-bfd ± SEM.  
*P < 0.05 compared to PyN number, unpaired Student’s t-test). (Lower) Labelled 
PyNs are distributed across cortical layers with more labelling in L5a and L4 
(n=3 brains from 2 litters). s, Presence of RGsLhx2+Fezf2− (RFP) and 
RGsLhx2+Fezf2+(EGFP) at E11.5 throughout cortical primordium revealed by 
intersection/subtraction fate-mapping with 24-hour pulse-chase in Lhx2-
CreER;Fezf2-Flp;IS mice, schematized in Fig. 1i (Also see Fig. 1j–n). These 
progenitors distribute in a medial high-lateral low gradient along the dorsal 
neuroepithelium, ending at the cortex–hem boundary (Hm). Rostral, Mid and 
Caudal sectioning levels show a caudal high-rostral low distribution of 
RGsLhx2+Fezf2− and RGsLhx2+Fezf2+. s’, Magnified view shows RGsLhx2+Fezf2− and 
RGsLhx2+Fezf2+ at multiple cell cycle stages with endfeet (arrow) and dividing soma 
(arrowhead) at ventricle wall (dashed line). t, Upper, total number 
of RGsLhx2+Fezf2+ (green) is approximately half that of RGsLhx2+Fezf2− (red). Lower, 
quantification of RGsLhx2+Fezf2− versus RGsLhx2+Fezf2+ at rostral (R), mid-level (M) 
and caudal (C) sections revealed their caudalhigh-rostrallow distribution. Scale 
bars: 20µm (high magnification) in a, c, e, g, i, k, s’; 100µm for all other panels.
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Extended Data Fig. 2 | See next page for caption.
Extended Data Fig. 2 | Lhx2 and Fezf2 driver lines precisely recapitulate 
endogenous developmental expression patterns. a, Anti-LHX2 
immunohistochemistry on a 24-hour pulse-chase in a E12.5 Lhx2-CreER;Ai14 
embryo revealed that 99.2% RGsLhx2+ express LHX2 (1410 of 1422 cells; n = 4 
embryos from 2 litters). High magnification images show colocalization 
(arrowheads). Note the medialhigh-laterallow gradient. b, 24-hour pulse-chase in a 
E10.5 Lhx2-CreER;Ai14embryo densely labelled RGs throughout the dorsal 
neuroepithelium, ending medially at the cortex–hem boundary (Hm). This 
expression recapitulated Lhx2 mRNA in-situ hybridization at E10.5 
(reproduced/adapted with permission from Development)68. c, Same 
experiment as in b done at E12.5. The medialhigh-laterallow gradient of RGsLhx2+  
is highly similar to Lhx2 mRNA expression (reproduced/adapted with 
permission from Development)69. d, Same experiment as in b done at E13.5. 
Note the reduction in RGsLhx2+ and concomitant increase in post-mitotic cells 
(arrowheads), in both the Lhx2 driver line and mRNA expression  
(ISH Data: Allen Brain Atlas: Developing Mouse Brain). e, anti-LHX2 
immunohistochemistry on a 24-hour pulse-chase in a E12.5 Fezf2-CreER;Ai14 
embryo reveals that 89.7% RGsFezf2+express LHX2 (376 of 419 cells; n =4 embryos 
from 2 litters); high magnification images show colocalization (arrowheads) 
and non-colocalization (arrow and encircled). f, 24-hour pulse-chase in a E10.5 
Fezf2-CreER;Ai14 embryo. The spatial extent of RGsFef2+ is restricted compared 
to RGsLhx2+ at this stage. This sparse labelling recapitulated Fezf2 mRNA 
expression at E10.5 (reproduced/adapted with permission from J Comp 
Neurol)70. g, Same experiment as in f done at E12.5. The medialhigh-laterallow 
distribution gradient of RGsFezf2+ is also seen with Fezf2 expression at this stage. 
Note RGsFezf2+ are sparsely labelled compared to RGsLhx2+using in-situ 
hybridization at E12.5 (reproduced/adapted via Open Access from Neural 
Dev)71. h, Same experiment as in f done at E13.5. The drastic decrease of 
Fezf2expression in RGsFezf2+ accompanied by an increase in post-mitotic PyNs 
(arrowheads) is comparable in both Fezf2-CreER; Ai14 and Fezf2 in-situ data  
(ISH Data: Allen Brain Atlas: Developing Mouse Brain). i, anti-LHX2 
immunohistochemistry on E13 Fezf2-FlpO;FSF-tdTomato embryo reveals that 
91.7% RGsFezf2+ express LHX2 (718 of 783 cells; n = 4 embryos from 2 litters). 
Similar to e. high magnification images show colocalization (arrowheads)  
and non-colocalization (asterisk). Note the medialhigh-laterallow gradient. Scale 
bars for low mag images = 100µm in a-i. Scale bars for high mag images = 20µm 
in a, e, i.
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Extended Data Fig. 3 | Fate-mapping neurogenic and intermediate 
progenitors. a, Fate-mapping strategy for intermediate progenitors (IPs) and 
indirect neurogenesis, used in c-e. Tbr2-CreER labels an IP and all of its progeny 
with a fluorescent marker when combined with Ai14 (Left). The intersection of 
Tis21-CreER and Tbr2-FlpER specifically targets neurogenic IPs when combined 
with the Ai65 intersectional reporter (Right). b, Simultaneous fate-mapping of 
different molecularly defined neurogenic RGs using an intersection/
subtraction reporter (IS) combined with Tis21-CreER and Fezf2-Flp drivers. This 
scheme is used in h-k. In RGsTis21+Fezf2−, Cre activates RFP expression only. In 
RGsTis21+Fezf2+, Cre and Flp recombinations remove the RFP cassette and activate 
EGFP expression. At a later stage when Fezf2 is only expressed in postmitotic 
deep layer PyNs, Tis21-CreER in RGs activates RFP expression in all of its 
progeny, but RFP is then switched to EGFP only in Fezf2+ PyNs expressing Flp.  
c, E16.5 IPs densely labelled by 12-hour pulse-chase in Tbr2-CreER;Ai14 mice; 
magnified view shows IP somata (arrowhead) away from the lateral ventricle 
(dashed line) lacking radial fibers and endfeet. d, Fate-mapping E16.5 IPs in 
Tbr2-CreER;Ai14mice labels PyNs in L2-3 cortex at P28. e, Intersectional 
fate-mapping of neurogenic IPs at E16.5 in Tis21-CreER;Tbr2-FlpER;Ai65 mice, as 
depicted in a, labelled L2-3 PyN progeny in P28 cortex. f, 48-hr pulse-chase in 
E10.5 Tis21-CreER;Ai14 embryo labels Tis21+ neurogenic progenitors (nRGs) and 
their postmitotic progeny throughout the neural tube, including dorsal 
pallium (high magnification). Self-renewing RGs are identified by their endfeet 
at the ventricular surface (arrowheads) and radial fibers (arrow).  
g, Fate-mapping of E10.5 nRGs to mature cortex reveals PyNs are distributed 
throughout cortical layers. Note that multipolar GABAergic interneurons 
(some in layer 1) derived from subpallium nRGs are also labelled (arrowheads). 
h, The presence of nRGsFezf2− and nRGsFezf2+ at E11.5 is revealed by intersection/
subtraction fate-mapping with 24-hour pulse-chase in Tis21-CreER;Fezf2-Flp;IS 
mice, schematized in b; magnified view shows RFP-labelled nRGsFezf2− and 
EGFP-labelled nRGsFezf2+. i, Fate-mapping E11.5 nRGs using Tis21-CreER; 
Fezf2-Flp;IS mice. The mixed RFP and EGFP clone is likely to have derived from a 
nRGFezf2−, which activated RFP expression in all progeny and EGFP expression 
was then switched on only in Fezf2+ postmitotic deep layer PyNs expressing Flp. 
j, k, More examples of differential fate-mapping of nRGsFezf2− and nRGsFezf2+ from 
E12.5 to the mature cortex using the scheme in b. The majority of clones consist 
of mixed RFP and EGFP PyNs ( j’), and rarely RFP-only ( j”) or EGFP-only PyNs (k). 
RFP-only clones (1 of 29) probably derive from nRGFezf2− whose progeny were all 
Fezf2− ( j”). EGFP-only clones (2 of 29) are derived from nRGsFezf2+, suggesting 
multipotency of RGsFezf2+ (k). Mixed RFP/EGFP clones are most prominent and 
are likely to result from Cre activation of RFP in nRGsFezf2− and subsequent Flp 
activation of EGFP in Fezf2+ L5/6 postmitotic PyNs (i,j’). Scale bars: 500µm in d, 
j, k; 100µm in d (high mag), e, f, g, h, i, j’,j”, k (high mag); 20µm in c, e, h.
Extended Data Fig. 4 | See next page for caption.
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Extended Data Fig. 4 | Comparison of new with existing driver lines in terms 
of areal and laminar patterns. a, Side-by-side comparison of Cre 
recombination patterns from 8 mouse driver lines characterized in this study 
(blue font) and 4 existing driver lines (black font) visualized through reporter 
expression (green; background autofluorescence in red), grouped according 
to IT, PT and CT projection classes. First row: coronal hemisections at Bregma 
-1.7 mm. Second row: Image panel showing cortical depth detailing cell body 
distribution pattern of PyN subpopulations within SSp-bfd taken from the 
hemisection above at level Bregma -1.7 mm. Third row: coronal hemisections at 
Bregma 0 mm. Image panel showing cortical depth detailing cell body 
distribution pattern of PyN subpopulations within MOp taken from the 
hemisection above at level Bregma 0 mm. For comparison to the PT driver 
Sim1-Cre transgenic line, see reference 37. b, Cortex-wide distribution patterns 
of PyN subpopulations viewed as cortical flatmaps in a side-by-side 
comparison of 8 newly generated (blue font) and 4 existing driver lines (black 
font): first row, normalized for each dataset’s total number of cells detected; 
second row, absolute scale per flatmap grid area, with maximum number of 
cells for any PyN subpopulation. Arrowheads indicate gaps in expression and 
labelling. b’ shows cortical flat-mapping coordinate space and two exemplary 
coronal hemisections describing the demarcations used to generate the 
cortical grid for flatmapping48. c, Overview of brain-wide cell body distribution 
patterns for each driver line. This table provides an overall impression of the 
recombination patterns in major adult brain regions in selected lines.  
d, Histograms showing normalized laminar distribution for six genetically 
targeted PyN subpopulations by cortical area. Brain-wide cortical depth 
quantification was performed based on cell detection by convolutional 
networks from GeneX-CreER driver lines crossed to Ai14 (R26-LSL-tdTomato), 
R26-LSL-h2b-GFP or Snap25-LSL-EGFP reporters and induced at the ages 
specified in Fig. 2, and P7 for Sema3E. The normalized cortical depth (0-1) was 
divided into 24 bins for the left histogram and 124 bins for the right plot in each 
panel. Abbreviations explained in the Supplementary Information. Scale bars: 
Last panel of first and third rows applies to all hemisections, 1mm; last panel of 
second and fourth rows applies to all cortical depth image panels, 200µm.
Extended Data Fig. 5 | Comparison of new with existing driver lines in terms 
of axon projections from SSp-bfd somatosensory cortex. a-c, STP images at 
the SSp injection site (first row, arrow head) and at selected subcortical 
projection targets for eight driver lines characterized in this study (coloured 
gene names code for IT-red, PT-blue and CT-purple) compared to seven existing 
driver lines (black gene names), with EGFP or EYFP expression from 
Cre-activated viral vector (green) and background autofluorescence (red). 
Arrows point to axons. a, IT drivers project to cortical and striatal targets. 
PyNsPlxnd1 project bilaterally to cortex and striatum; PyNsCux1 project bilaterally 
to cortex but not to striatum. b, PT drivers project to many corticofugal targets 
including brainstem and spinal cord. PyNsFezf2, PyNsAdcyap1 and PyNsTcerg1l project 
to multiple ipsilateral targets and to the contralateral brainstem (arrows).  
c, CT drivers project predominantly to the thalamus. PyNsTbr1 project bilaterally 
to cortex and to ipsilateral thalamus, PyNsFoxp2 and PyNsTle4 project to the 
ipsilateral cortex and thalamus. Scale bars: first row in c (applies to first row),  
1 mm; second to eighth rows in c (applies to each respective row), 200 µm; CST 
panel (bottom row) in c applies to entire row, 100 µm. Asterisks in b & c indicate 
presence of passing fibers. A side-by-side list of axon projection matrix for all 
these lines is presented in Fig. 3d.
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Extended Data Fig. 6 | See next page for caption.
Extended Data Fig. 6 | Molecular validation and developmental 
characterization of PyN driver lines. a, d, Low magnification images of 
sections of somatosensory cortex (SSp) at P7 stained with antibodies against 
CTIP2, CUX1, and tdTomato from PyN-CreER;Ai14 mice induced with tamoxifen. 
Inset to the right shows markers and Tomato+cell distributions across layers. 
Fezf2-, Tcerg1l-, Adcyap1- and Tle4-CreER;Ai14 were induced at E16.5 and 
collected at P7. Tbr1-, Cux1- and Plxnd1-CreER;Ai14 were induced at P4 and 
collected at P7. Tbr2-CreER;Ai14 was induced at E16.5 (not shown) or E17.5 and 
collected at P7. Lhx2-CreER;Ai14 was induced at P3 and collected at P7.  
a’, d’, Histograms showing radial distribution of Tomato+ cells in the cortical 
plate, in the region corresponding to SSp. In brief, in CUX1- and CTIP2-stained 
sections, Tomato+ cell depths relative to the thickness of the cortex were 
measured, as well as the limits of the areas occupied by CUX1+ or CTIP2HIGH cells, 
shown in green (layers 2-4) and blue (layer 5b) bars, respectively (average 
relative values for the same sections, gray shading corresponds to 1 SD). For 
Tbr2-CreER;Ai14, mice induced at E16.5 or E17.5 were quantified separately, 
showing the later induction (darker red) results in more superficial labelling. 
Quantifications were made from 4-10 sections from 2-3 different mice for each 
line. b, e, Magnification of Tomato+ cells in sections co-stained against CUX1 
and CTIP2, LDB2 (enriched in PT), FOG2 (expressed in CT), BRN2, or SATB2 
(expressed in IT). Arrowheads show double-positive cells; asterisks show 
Tomato+ cells not expressing the marker. c, f, Percentage of Tomato+ cells 
stained with each antibody. Quantifications were done in equivalent areas 
(320µm by 320µm) within the SSp centered in the specified layers. Each dot is 
an area from a different section, for which the percentage of double positive 
cells was calculated. Bars are mean+SD. Quantifications were made from 4-8 
sections from 2-3 different mice for each line. Tbr2-CreER;Ai14 labelled CUX1+, 
SATB2+, BRN2+ IT in the most superficial layers 2-3, irrespective of their 
induction time. Lhx2-CreER;Ai14 and Cux1-CreER;Ai14 labelled CUX1+, SATB2+, 
BRN2+ IT deeper in layers 2-3. Plxnd1-CreER;Ai14 labelled SATB2+, BRN2+cells in 
layer 5A, as well as CUX1+, SATB2+, BRN2+ cells in layer 4. No cells were found in 
layer 5B. Tcerg1l-CreER;Ai14 and Adcyap1-CreER;Ai14 labelled sparse LDB2+, 
CTIP2+ PT in layer 5. Fezf2-CreER;Ai14 extensively labelled PT in layer 5 that were 
LDB2+, CTIP2+, as well as some CT in layer 6 expressing CTIP2 and FOG2. Tle4-
CreER;Ai14 and Tbr1-CreER;Ai14 labelled CT expressing FOG2 and CTIP2 (and 
lower levels of LDB2) in layer 6. Tle4-CreER;Ai14 also labelled some LDB2+, 
CTIP2+ cells in layer 5 (PT), whereas Tbr1-CreER;Ai14 also labelled some CUX1+, 
BRN2+ IT in layer 2/3. g, Fate-mapping of PyNsTbr1 using Tbr1-CreER; Ai14 mice. 
Tamoxifen induction at E14.5 densely labelled L6 CT cells with minor labelling 
of cells in layers 3-5. h, Tamoxifen induction at E15.5 labelled L6 CT cells.  
i, Tamoxifen induction at P4 labelled L6 CT cells and also a subset of L2/3 cells.  
A subset of adult PyNsTbr1 labelled from E14.5, E15.5 and P4 induction project to 
contralateral cortex via the corpus callosum (arrowheads, g’, h’, i’). Scale bars: 
g-i, low magnification, 500µm; high magnification, 100µm.
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Extended Data Fig. 7 | Anterograde tracing, registration to CCFv3 and 
analysis of PyN projections from SSp-bfd. a, Summary table of driver lines 
and viral vectors used for anterograde tracing from PyNs in primary 
somatosensory cortex, related to Fig. 3. b, Virus injection centroid coordinates 
across single driver experiments in CCFv3 space on a dorsal whole-brain view. 
c-e, Whole-brain 3D renderings of axon projections registered to CCFv3 and 
main projection targets for each PyN subpopulation in the SSp-bfd. f, Axon 
projection matrix from SSp-bfd to 321 ipsilateral and 321contralateral targets 
(in columns), each grouped under 12 major categories (top row) for each of the 
driver lines generated in this study highlighted in Fig. 3, and presented 
alongside several previously published driver lines (IT lines: Cux2, Sepw1, 
Rasgrf2, Tlx3; PT lines: Rbp4, Sim1; CT lines: Ntsr1) for comparison (see 
Extended Data Fig. 5 for images). Colour shades in each row represent fraction 
of total axon signal measured from a single experiment per brain area; signal in 
the inj. site (white) was subtracted from total axon signal to show the fraction of 
projections outside the inj. site. PyNsPlxnd1 project bilaterally to CTX and Str; 
PyNsCux1 project bilaterally to CTX but minimally to Str; PyNsFezf2, PyNsAdcyap1 and 
PyNsTcerg1l project to multiple ipsilateral targets, and contralateral brainstem 
(arrows); PyNsTbr1 project bilaterally to CTX and ipsilaterally to thalamus, 
PyNsFoxp2 and PyNsTle4 project to the ipsilateral CTX and thalamus. Scale bar in d 
(for all 3D renderings in c-e), 2 mm. Asterisks in f indicate passing fibers. 
Abbreviations explained in the Supplementary Information.
Extended Data Fig. 8 | Anterograde tracing of axon projections from one or 
two PyN populations using single- or double-allele driver mice, 
respectively. a, 3D rendering from STP imaging of PyNsSema3E projection 
pattern based on injection of AAV9-Ef1a-DIO-ChR2-EYFP followed by 
tamoxifen induction (2 days post-injection): dorsal view (left) and parasagittal 
view (right). b, Coronal section containing injection site in a Sema3E-CreER;Ai14 
mouse. c, PyNsSema3E project via the cerebral peduncle (cp) to the pons (Pn). 
PyNsSema3E infected with AAV9-Ef1a-DIO-ChR2-EYFP express EYFP/tdTomato; 
all other PyNsSema3Eexpress tdTomato by tamoxifen induction. d, PyNsSema3E at 
injection site, showing somata in layer 5 with slender tufted apical dendrites.  
e, PyNsSema3E axons in thalamus with large boutons in POm (e’). f-r, Simultaneous 
anterograde tracing from two driver allele-defined PyN populations.  
f, Schematic showing simultaneous anterograde tracing from PyNs targeted by 
Fezf2-Flp (green) and Tle4-CreER (red) with co-injection of Flp- and  
Cre- dependent AAVs expressing EGFP and mCherry, respectively (g-l).  
g, PyNsFezf2 and PyNsTle4 at the injection site occupying mainly L5B and L6, 
respectively. h, PyNFezf2 and PyNTle4 projection patterns converge in primary 
thalamus, VPM, whereas PyNsFezf2 collaterals (asterisk) extend medially to 
higher order thalamic nuclei. i, PyNsFezf2 (green) extend axon collaterals in Str, 
whereas PyNsTle4 (red) pass through en route to thalamus. j-l, PyNsFezf2 but not 
PyNsTle4 project to multiple other corticofugal targets, including SC, Pn and 
cSp5. m, Schematic showing simultaneous anterograde tracing from PyNs 
targeted by Plxnd1-Flp (green) and Fezf2-CreER (red) with co-injection of Flp- 
and Cre-dependent AAVs expressing EGFP and mCherry, respectively (n-r).  
n, PyNsPlxnd1 and PyNsFezf2 at the injection site in motor cortex occupying mainly 
L5A and L5B/L6, respectively. o-p, PyNsFezf2 but not PyNsPlxnd1 project to Thal (o) 
and medulla (p). q-r, PyNsPlxnd1 and PyNsFezf2 project to ipsilateral Str with 
overlapping terminals (r), whereas PyNsPlxnd1 but not PyNsFezf2 project to 
contralateral Str (q). Asterisks indicate PyNFezf2 collaterals and arrows indicate 
PyNPlxnd1 collaterals. Scale bars: a, 2 mm; b, 1 mm; c-e, 200 µm; e’, 100µm;  
l (applies to g-l), 200µm; n-r, 200µm; q’ & r’, 100µm.
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Extended Data Fig. 9 | See next page for caption.
Extended Data Fig. 9 | Intersectional dissection of PyN subpopulations.  
a, Strategy for retrograde labelling of PyNFezf2 subpopulations by viral or tracer 
injections from the spinal cord of Fezf2-CreER mice. b, PyNFezf2corticospinal 
neurons in L5B of sensorimotor cortex labelled by retroAAV-flex-tdT.  
c, Fezf2CreER;Ai14 captures >95% of retrogradely labelled Fluorogold+ 
corticospinal neurons. Inset arrows indicate Fezf2 and Fluorogold co-
labelling. d, An intersection-subtraction (IS) reporter strategy to label 
projection-defined PyNFezf2 subpopulations (retroAAV-Flp, EGFP) within the 
overall population (Fezf2-CreER, RFP). e, f, In motor cortex (MO), thalamus-
projecting PyNsFezf2 are located in upper L5B, whereas medulla-projecting 
PyNsFezf2 are located in lower L5B. g, In SSp-bfd, PyNsFezf2 labelled from a defined 
projection target (EGFP) show more restricted sublaminar position in L5 
compared to overall population (RFP). h, Normalized cortical depth 
distributions of overall PyNFezf2 population (leftward curve) and of each target-
defined subpopulation (rightward curves) in SSp-bfd. i, In Fezf2-CreER;Pv-Flp;IS  
triple allele mice, PV- and PV+ PyNsFezf2 are distinguished by their expression of 
RFP and EGFP, respectively, in SSp-bfd. j, Sample voltage responses induced by 
current injection from a pair of PV+ (EGFP) and PV- (RFP) PyNsFezf2 by whole-cell 
patch recording in a cortical slice., Electrophysiological differences between  
5 pairs of PV+ and PV- PyNsFezf2: resting membrane potential (Vm, -66.5 ± 1.6 vs. 
−70.7 ± 1.5 mV, mean ± s.e.m.; p = 0.0014, Student’s paired t-test); input 
resistance (MΩ, 60.1 ± 7.8 vs. 108.7 ± 45.4 MΩ, mean ± s.e.m.; p = 0.23, Student’s 
paired t-test). k, PyNsFezf2 retrogradely labelled from thalamus and medulla are 
distributed in the upper or lower L5B, respectively, in the motor cortex (related 
to e, f). In a Fezf2-CreER;IS mouse (upper panels), retroAAV-Flp was injected in 
thalamus. In a Fezf2-CreER mouse (lower panels), retroAAV-Flex-GFP was 
injected into the medulla. l-q, Representative hemi-sections containing the  
SS-bfd showing the labelling patterns of PyNsFezf2, PyNsPlxnd1, PyNsTle4 subsets  
by retroAAV-Flp injections at subcortical targets (arrows) in PyN-CreER;IS mice. 
In each panel, the overall PyN-CreER population was labelled by RFP, whereas 
the target-specific subset expressed EGFP. Corresponding cortical soma depth 
distribution is shown for Fezf2 hemisections in g, h and to the right for Plxnd1 
(p) and Tle4 (q) hemisections (n = 2 for each target). PyNsTle4 project to VPM and 
consist of two subpopulations with apical dendrites in L4/5 (q’) and L1 (q’’), 
respectively, indicated by arrows. r, Retrograde targeting of striatum-
projecting PyNsPlxnd1 by injection of retroAAV-FLEX-tdTomato in striatum.  
s, Coronal section displays injection site (arrowhead) and collaterals of 
retrogradely labelled PyNsPlxnd1 in contralateral striatum (arrow). t-w, Laminar 
patterns of retrogradely labelled PyNsPlxnd1 reveal that L5A PyNsPlxnd1project to 
both ipsi- and contralateral striatum, whereas L2/3 PyNsPlxnd1 project to 
ipsilateral striatum (t, u, v, w). x, Validation of four PyN driver lines by 
fluorescence in situ hybridization (Plxnd1, Fezf2, Tcerg1l) and antibody (TLE4) 
using Plxnd1-, Fezf2-, Tcerg1l-CreER driver mice bred with a Rosa26-
loxpSTOPloxp-H2bGFP reporter. H2bGFP signal colocalized with mRNA in situ 
signals of Plxnd1, Fezf2 and Tcerg1l. In Tle4-Cre;Ai14 mice, RFP signals 
colocalized with immunofluorescence of the TLE4 antibody. Scale  
bars: b, l-q, 500µm; c, e, g, q’, q’’, x, 50µm; i, s-w, 100µm. Abbreviations 
explained in the Supplementary Information.
Article
Extended Data Fig. 10 | Strategy to target PyN subpopulations combining 
driver line, projection target and cortical location. a, Left schematic shows 
the ‘triple trigger’ strategy for combinatorial targeting by marker, axon target 
and soma location. Upon Cre and Flp recombination, the dual-tTA reporter 
expresses the transcription activator, tTA. In a Fezf2-CreER;dual-tTA mouse, 
tamoxifen induction combined with retrograde retroAAV-Flp injection at the 
target, cSp5 or SC, activate tTA expression in cSp5- or SC-projection PyNsFezf2 
across cortical areas, and AAV-TRE-mRuby anterograde injection at SSp-bfd 
then labels projection-defined PyNsFezf2 in the SSp-bfd. Coronal images of 
PyNsFezf2 in SSp-bfd with projection to SC or cSp5, displaying axon collaterals at 
various subcortical targets, including Str, ZI, thalamus, pons. b, Left schematic 
depicts the control experiment for use of Cre- and Flp-dependent dual-tTA 
reporter for target-defined axon projection mapping of PyNsFezf2. Co-injection 
of a Cre-dependent AAV-DIO-ChR2-EYFP (green, positive control) and 
tTA-activated AAV-pHB-TRE-mRuby2 (red, negative control), followed by 
tamoxifen induction, in absence of Flp confirms dependence of reporter on 
both Cre and Flp recombination. Example images of anterograde injection site 
(SSp-bfd) and axon projection targets of several indicated ipsi- and 
contralateral sites displaying EGFP+PyNsFezf2 axons from Cre-dependent AAV, 
but no mRuby2+ axons (in absence of Flp), demonstrating the dependence of 
‘triple trigger’ strategy on intersection of Cre and Flp. Scale bars: a-b, 200 um.
Extended Data Fig. 11 | A subset of PyNsFezf2 manifest IT features.  
a-c, Retrograde injection of CTB (green) in the lateral striatum labelled a set of 
contralateral (a, b) and ipsilateral (c) PyNsFezf2 at the top of L5B in SSp-bfd. The 
whole population of PyNsFezf2 labelled in Fezf2-CreER;Ai14. Depth distributions 
in c compares total CTB-labelled PyNs (green), CTB+ Fezf2+ (magenta), and the 
whole population of PyNsFezf2 labelled in Fezf2-CreER;Ai14. d, e), Retrograde 
injection of CTB in the lateral striatum labelled a set of ipsilateral (d, d’) and 
contralateral (e, e’) PyNsFezf2 at the top of L5B in MO. f, Fezf2 and Plxnd1 mRNAs 
are co-expressed (f’, arrows) in a subset of L5 PyNs in the L5B/L5A border 
region. g, h, Intersection/subtraction mapping in Fezf2-CreER;Plxnd1-Flp;IS 
mice revealed a small set of PyNsFezf2/Plxnd1 (EGFP) located at the top of L5B 
among other PyNsFezf2 (RFP). Magnified insets are from the boxed regions in 
each panel. DAPI (blue) counterstain in c, f-h. Scale bars: a, g, 500µm; b, c, d, e, 
f, h, 50µm.
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Extended Data Table 1 | Summary of information on the expression and molecular function of genes selected to generate 
new driver lines and the targeted progenitor and PyN types





NE: neuroepithelium; RG: radial glia; IP: intermediate progenitors; nRG: neurogenic RG; TF: transcription factor; CAM: cell adhesion molecule
Lhx210,32,53-57
TF; homeodomain
Cortical primordium formation; 
NE proliferation and differentiation; 
RG fate restriction; upper layer PyN
differentiation; timing of gliogenesis
E8-E10: NE; 
E10-E17: RGs; 
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Data collection 1. Serial two photon tomopraphy (STP) datasets were collected using the commercial set-up by TissueVision (Cambridge, MA), followed by 
Fiji-based stitching, Elastix-based registration, segmentation, quantification and data presentation, as described in Ragan et al 2012  and 
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distributions and cortical flatmapping as in Kim et al 2015. 
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3. Custom Matlab (Matlab_R2018a) code for both cortical depth distributions and anterograde tracing projection matrix is available upon 
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Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size Sample sizes were estimated on the basis of previous studies using similar methods and analyses (Oh et al 2014, doi: 10.1038/nature13186.; 
Kim et al 2015; Harris et al 2019, doi: 10.1038/s41586-019-1716-z). A full list of data acquired is provided in Tables S1 and S2. Based on 
consistency of results between litters and between individuals within a given litter, a sample size of 2 litters was considered sufficient for all 
embryonic characterization.
Data exclusions All analyzed data was included in the study. Prior to STP analysis, datasets were screened for standard quality control by two independent 
reviewers according to pre-established criteria.
Replication -The labeling patterns achieved from the strategies described here reveal a high degree of replicability across animals. A full list of data 
acquired for cell distribution and virus injections is provided in Supplementary Tables 4 and 5, respectively. These tables detail experiments 
based on knock in Cre/Flp driver lines bred with appropriate reporters for cell distribution analysis and injected with virus for axon projection 
mapping. 
-Oh et al 2014 and Harris et al 2019 demonstrated a high degree of replicability across animals for anterograde virus tracing. Based on this 
rationale, they confidently and comprehensively sampled with n=1 experiment per source area and driver line. 
-Here we utilized a minimum n=2-3 for each cell distribution and virus tracing experiment in adult animals, and spanning a minimum of 2 
litters for short-pulse embryonic experiments. For Sema3E and Tcerg1l, due to the high replicability mentioned above, we analyzed a single 
successful injection for each driver line.
Randomization Not relevant because there was no group allocation.
Blinding Not relevant to this study because there was no group allocation.
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
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Antibodies used Anti-GFP (1:1000, Aves, GFP-1020); anti-RFP (1:1000, Rockland Pharmaceuticals, 600-401-379); anti-mCherry (1:500, OriGene 
AB0081-500);  anti-mKate2 for Brainbow 3.0 (gift of Dr. Dawen Cai, U Michigan); anti-SATB2 (1:20, Abcam ab51502); anti-CTIP2 
(1:100, Abcam 18465); anti-CUX1 (1:100, SantaCruz 13024); anti-LDB2 (1:200, Proteintech 118731-AP); anti-Fog2 (1:500, SantaCruz 
m-247), anti-LHX2 (1:250, Millipore-Sigma ABE1402) and anti-Tle4 (1:300, Santa Cruz sc-365406).
Validation All antibodies are commonly used in the field and have been validated in previous publications/by the manufacturer, as detailed 
here: 
-anti-GFP (Aves, GFP-1020): validated by manufacturer by immunohistochemistry (1:500) using transgenic mice expressing GFP 
-anti-RFP (Rockland Pharmaceuticals, 600-401-379): validated by the manufacturer by immunoelectrophoresis resulting in a single 
precipitin arc against anti-Rabbit Serum and purified and partially purified Red Fluorescent Protein (Discosoma).  No reaction was 
observed against Human, Mouse or Rat serum proteins. https://rockland-inc.com/store/Antibodies-to-GFP-and-Antibodies-to-
RFP-600-401-379-O4L_24299.aspx 
-anti-mCherry (OriGene AB0081-500): https://www.origene.com/catalog/antibodies/primary-antibodies/ab0081-500/mcherry-goat-
polyclonal-antibody 
-anti-mKate2 for Brainbow 3.0 (gift of Dr. Dawen Cai, U Michigan): validated in Cai et al 2013 (doi: 10.1038/nmeth.2450) 
-anti-SATB2 (Abcam ab51502): https://www.abcam.com/satb2-antibody-satba4b10-c-terminal-ab51502.html 
-anti-CTIP2 (Abcam 18465): https://www.abcam.com/ctip2-antibody-25b6-chip-grade-ab18465.html  
-anti-CUX1 (SantaCruz 13024): https://www.scbt.com/scbt/product/cdp-antibody-m-222  
-anti-LDB2 (Proteintech 118731-AP): https://www.ptglab.com/Products/LDB2-Antibody-11873-1-AP.htm#datasheet 
-anti-FOG2 (SantaCruz m-247): widely used in the field (e.g. Alfano et al 2014, doi: 10.1038/ncomms6632) 
-anti-LHX2 (Millipore-Sigma ABE1402): https://www.emdmillipore.com/US/en/product/Anti-LHX2-Antibody,MM_NF-ABE1402 
-anti-Tle4 (SantaCruz sc-365406): https://www.scbt.com/p/tle4-antibody-e-10
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals -Species/strain: Mus musculus, C57Bl/6J or Swiss Webster  
Cre/Flp driver knock in and reporter lines used: Lhx2-2A-CreER (JAX stock # 036293), PlexinD1-2A-CreER (JAX stock # 036294), 
PlexinD1-2A-flpO (JAX stock # 036295), Fezf2-2A-CreER (JAX stock # 036296), Fezf2-2A-flpO (JAX stock # 036297), Tcerg1l-2A-CreER 
(JAX stock # 034000), Adcyap1-2A-CreER (JAX stock # 033999), Sema3E-CreER (Y. Yoshida; Pecho-Vrieseling et al., 2009, doi: 10.1038/
nature08000); Tle4-2A-CreER (JAX stock # ), FoxP2-IRES-Cre (R. Palmiter, Rousso et al., 2016, doi: 10.1016/j.celrep.2016.04.069), 
Tbr1-2A-CreER (JAX stock # 036299), Cux1-2A-CreER (JAX stock # 036300), Tbr2-2A-CreER (JAX stock # 036301), Tbr2-2A-FlpER, 
Tis21-2A-CreER (JAX stock # 036303), dual-tTA (JAX stock # 036304). 
Other Cre/Flp driver knockin and reporter lines used: PV-2A-FlpO (JAX stock # 022730), Ai14 (JAX stock # 007908), Ai65 (JAX stock # 
021875), LSL-h2b-GFP (He et al 2016), LSL-Flp (JAX stock # 028584), IS (JAX stock # 028582), Snap25-LSL-EGFP (JAX stock # 021879), 
RGBbow (JAX stock # 028583), Cux2-Cre (Franco et al., Science 2012, RRID:MMRRC_031778-MU), Cux2-CreERT2 (Franco et al., 
Science 2012, RRID:MMRRC_032779-MU), Ntsr1-Cre_GN220 (Gerfen et al., Neuron 2013), Rasgrf2-T2A-dgFlpO (JAX stock# 029589), 
Rbp4-Cre_KL100 (JAX stock # 031125), Sepw1-Cre_NP39 (JAX stock # 037622), Sim1-Cre_KJ18 (JAX stock # 031742), Tlx3-Cre_PL56 
(JAX stock # 036547) 
New driver and reporter lines have been deposited to the Jackson Laboratory for wide distribution. 
-Age: embryonic E11.5, E12.5, E13, E13.5, E14.5, E17; postnatal stages P5, P7, 1-6 months 
-Sex: males and females 
All details appear in Supplementary Tables 1, 3, 4, 5, 7
Wild animals The study did not involve wild animals.
Field-collected samples The study did not involve field-collected samples.
Ethics oversight All experimental procedures were carried out in accordance with NIH guidelines and approved by the Institutional Animal Care and 
Use Committees of Cold Spring Harbor Laboratory and Harvard University.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
